Ion Channels as a Therapeutic Target: Drug Design and Pharmacological Investigation
- PMID: 38203342
- PMCID: PMC10779005
- DOI: 10.3390/ijms25010171
Ion Channels as a Therapeutic Target: Drug Design and Pharmacological Investigation
Abstract
This Special Issue intends to illustrate the novelties in the field of ion channels [...].
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Møllerud S., Hansen R.B., Pallesen J., Temperini P., Pasini D., Bornholt J., Nielsen B., Mamedova E., Chalupnik P., Paternain A.V., et al. N-(7-(1 H-Imidazol-1-yl)-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2 H)-yl)benzamide, a newkainate receptor selective antagonist and analgesic: Synthesis, X-ray crystallography, structure-affinity relationships, and in vitroand in vivo pharmacology. ACS Chem. Neurosci. 2019;10:4685–4695. doi: 10.1021/acschemneuro.9b00479. - DOI - PubMed
-
- Pallesen J., Møllerud S., Frydenvang K., Pickering D.S., Bornholdt J., Nielsen B., Pasini D., Han L., Marconi L., Kastrup J.S., et al. N1-substituted quinoxaline-2,3-diones as kainate receptor antagonists: X-ray crystallography, structure-affinity relationships, and in vitro pharmacology. ACS Chem. Neurosci. 2019;10:1841–1853. doi: 10.1021/acschemneuro.8b00726. - DOI - PubMed
-
- Narcisi R., Koevoet W., van Osch G. Expansion and Chondrogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stromal Cells. Methods Mol. Biol. 2021;2221:15–28. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources